Epstein Secrets

companies preparing to merge, in light of the bombshell testimony of a U. S. Department of Justice whistleblower who claimed that Attorney General William Barr has targeted cannabis industry mergers for heightened scrutiny that may not be warranted on traditional antitrust grounds. [Continue Reading] Law36

Barr might wait until after Election Day to initiate prosecutions related to U.S. Attorney John Durham's ongoing probe into FBI and CIA misconduct. Barr told Fox News last month that Americans be able to recognize "some" of the names under investigation in Durham's probe, and that he is "very troubl

To Expand Arthrex To All," Unattributed, July 06, 2020, 11:21 PM Sanofi-Aventis has urged the U.S. Supreme Court to weigh in on its patent row with Mylan, arguing in a recent petition that the Federal Circuit's decision that the structure of the Patent Trial and Appeal Board is unconstitutional shoul

en our government and a serial child molester — who could have conceived of that?" Scarola said. Sen. Ben Sasse questioned attorney general nominee William Barr about the Jeffrey Epstein case on January 15, 2019, getting the nominee to commit to having the Department of Justice look into the handling of that

Sasse questioned attorney general nominee William Barr about the Jeffrey Epstein case on January 15, 20

ritage coordinated a response with counsels for both Teva and Mylan. "Spoke with my colleague [redacted] in DC who is doing the response letter for Mylan. Her husband works for [redacted] and he is doing the response for Teva," wrote Heritage's outside counsel to the company's CEO Jeff Glazer. "They

en our government and a serial child molester — who could have conceived of that?" Scarola said. Sen. Ben Sasse questioned attorney general nominee William Barr about the Jeffrey Epstein case on January 15, 2019, getting the nominee to commit to having the Department of Justice look into the handling of that

Sasse questioned attorney general nominee William Barr about the Jeffrey Epstein case on January 15, 20

ritage coordinated a response with counsels for both Teva and Mylan. "Spoke with my colleague [redacted] in DC who is doing the response letter for Mylan. Her husband works for [redacted] and he is doing the response for Teva," wrote Heritage's outside counsel to the company's CEO Jeff Glazer. "They

ng to court documents. Two companies, Lannett and Barr Laboratories, settled with Celgene. Mylanâe™s sui

sent approval from the F.D.A., Celgene would request more information before agreeing to distribute the drug. But according to court documents in the Mylan case, these requests were laborious, irrelevant and time consuming.", "type": "text"}, ("identifier":" anf-body- 46", "inlineTextStyles": | {"range":